Related Experiment Video
Updated: Mar 27, 2026
07:41
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
9.6K
Ligands for cannabinoid receptors, promising anticancer agents
Marjan Nikan1, Seyed Mohammad Nabavi2, Azadeh Manayi1
1Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Life Sciences
|January 15, 2016
Summary
Cannabinoids, compounds from cannabis, interact with the body's endocannabinoid system. Research suggests these compounds may help suppress cancer progression and reduce tumor size and pain.
Area of Science:
- Pharmacology
- Oncology
- Neuroscience
Background:
- Cannabinoids are unique compounds found in cannabis.
- The endocannabinoid system, including CB1 and CB2 receptors, plays a role in various physiological processes.
- Endocannabinoids are neuromodulators found in the body, particularly the brain.
Purpose of the Study:
- To review the effects of cannabinoids on different types of cancer.
- To explore the potential of modulating the endocannabinoid system for cancer treatment.
Main Methods:
- Review of recent studies on cannabinoid compounds and cancer.
- Analysis of cannabinoid receptor expression in cancer cell lines.
- Investigation of the impact of cannabinoids on tumor growth, cell proliferation, and apoptosis.
Main Results:
- CB receptors are over-expressed in cancer cell lines.
- Cannabinoids can reduce tumor size by decreasing cell proliferation, inducing cell cycle arrest, and promoting apoptosis.
- Cannabinoids may also alleviate cancer-related pain.
Conclusions:
- Modulating the endocannabinoid system, via FAAH inhibition or cannabinoid application, shows promise for treating certain cancer subtypes.
- Cannabinoids offer a potential therapeutic avenue for cancer management.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
927
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
927
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:57Targeted Cancer Therapies
1.8K
1.8K
02:34Inhibition of Cdk Activity
6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
01:15G Protein-coupled Receptors
19.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
19.5K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
744
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
744